Gonadectomy influences blood pressure through the kallikrein-kinin system

Kidney and Blood Pressure Research

Volumn 32, Issue 5, 2009, Pages 342-348

  Azurmendi, Pablo J ^a,b   Oddo, Elisabet M ^a   Obika, Leonard F ^c   Corbera, Natalia L ^a   Martín, Rodolfo S ^a,b   Ibarra, Fernando R ^a   Arrizurieta, Elvira E ^a,b  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Blood pressure; Ovariectomy; Renal cortex; Renal kallikrein

Indexed keywords

KALLIKREIN; KININ;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; KALLIKREIN KININ SYSTEM; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SYNTHESIS;

ANIMALS; APROTININ; BLOOD PRESSURE; FEMALE; GLOMERULAR FILTRATION RATE; HEMOSTATICS; KALLIKREIN-KININ SYSTEM; KALLIKREINS; KIDNEY; KININS; MALE; MODELS, ANIMAL; ORCHIECTOMY; OVARIECTOMY; RATS; RATS, WISTAR;

EID: 70349833351     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000245037     Document Type: Article

References (32)

1. Madeddu P, Emanueli C, El-Dahr S: Mechanisms of disease: the tissue kallikrein kinin system in hypertension and vascular remodeling. Nat Clin Pract Nephrol 2007; 3: 208-221.
2. Busse R, Fleming I: Regulation and functional consequences of endothelial nitric oxide formation. Ann Med 1995; 27: 331-340.
3. Vanhoutte PM, Boulanger CM, Mombouli JV: Endothelium-derived relaxing factors and converting enzyme inhibition. Am J Cardiol 1995; 76: 3E-12E.
4. Duka A, Duka I, Gao G, Shenouda S, Gavras I, Gavras H: Rol of bradykinin B1 and B2 receptors in normal blood pressure regulation. Am J Physiol Endocrinol Metab 2006; 291: E268-E274.
5. Cockcroft JR, Chowienczyk PJ, Brett SE, Bender N, Ritter JM: Inhibition of bradykinin-induced vasodilation in humans forearm vasculature by icatibant, a potent B2-receptor antagonist. Br J Clin Pharmacol 1994; 38: 317-321.
6. Panza JA, García CE, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd: Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995; 91: 1732-1738.
7. Batenburg WW, Popp R, Fleming I, De Vries R, Garrelds IM, Saxena PR, Danser AH: Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF? Br J Pharmacol 2004; 142: 125-135.
8. Granger JP, Hall JE: Acute and chronic actions of bradykinin on renal function and arterial pressure. Am J Physiol 1985; 248:F87-F92.
9. Martin R, Nesse A, Arrizurieta de Muchnik E: Urinary kallikrein excretion, renal kallikrein content and renal plasma flow in the rat. Medicina (Buenos Aires) 1979; 39: 467-471.
10. Madeddu P, Oppes M, Soro A, Dessi'-Fulgheri P, Glorioso N, Bandiera F, Manunta P, Rubattu S, Rappelli A: The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives. J Hypertens 1987; 5: 581-586.
11. Pizard A, Richter C, Bouby N, Picard N, Meneton P, Azizi M, Alhene-Gelas F: Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney. Biol Chem 2008; 389: 701-706.
12. Oddo EM, de Luca Sarobe V, Krmar R, Periz GA, Herrera H, Martín RS, Ibarra FR, Arrizurieta EE: Urinary kallikrein and blood pressure-gender- different response to potassium supplementation in SHR. Role of aldosterone. Nephron Physiol 2008; 108:p37-p45.
13. Young MK Jr, Raisz LG: An anthrone procedure for determination of inulin in biological fluids. Proc Soc Exp Biol Med 1952; 80: 771-774.
14. Lomez ES, Araujo RC, Bader M, Pesquero JB, Pesquero JL: Tonin and kallikrein in the brain of transgenic rat line expressing human tissue kallikrein. Hypertension 2002; 39: 229-232.
15. Amundsen E, Putter J, Frieberger P, Knos M, Larsbraten M, Cleason G: Methods for determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med Biol 1979; 120: 83-85.
16. Kauker ML, Baez PG, Nasjletti A: Augmentation by aprotinin of the renal response to vasopresin. Kidney Int 1987; 31: 1092-1096.
17. Amann K, Gassmann P, Buzello M, Orth SR, Törnig J, Gross ML, Magener A, Mall G, Ritz E: Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats. Kidney Int 2000; 58: 153-161.
18. Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, Henk S, Breipohl G, Köning W, Knolle J, Schölkens BA: HOE-140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol 1991; 102: 774-777.
19. Margolius HS, Horwitz D, Pisano JJ, Keiser HR: Urinary kallikrein excretion in hypertensive man: relationships to sodium intake and sodium-retaining steroids. Circ Res 1974; 35: 820-825.
20. Berry TD, Hasstedt SJ, Hunt SC, Wu LL, Smith JB, Ash KO, Kuida H, Williams RR: A gene for urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 1989; 13: 3-8.
21. Favaro S, Baggio B, Antonello A, Zen A, Cannella G, Todesco S, Borsatti A: Renal kallikrein content of spontaneous hypertensive rats. Clin Sci Mol Med 1975; 49: 69-71.
22. Pesquero JB, Bader M: Genetically altered animal models in the kallikrein-kinin system. Biol Chem 2006; 387: 119-126.
23. Wang J, Xiong W, Yang Z, Davis T, Dewey MJ, Chao J, Chao L: Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 1994; 23: 236-243.
24. Wang DZ, Chao L, Chao J: Hypotension in transgenic mice overexpressing human bradykinin B2 receptor. Hypertension 1997; 29: 448-493.
25. Madeddu P, Parpaglia PP, Demontis MP, Varoni MV, Fattaccio MC, Anania V, Glorioso N: Early blockade of bradykinin B2 receptors alters the adult cardiovascular phenotype in rats. Hypertension 1995; 25: 453-459.
26. Madeddu P, Emanueli C, Song Q, Varoni MV, Demontis MP, Anania V, Glorioso N, Chao J: Regulation of bradykinin B2-receptor expression by oestrogen. Br J Pharmacol 1997; 121: 1763-1769.
27. Madeddu P, Glorioso N, Maioli M, Demontis MP, Varoni MV, Anania V, Xiong W, Chai K, Chao J: Regulation of rat renal kallikrein expression by estrogen and progesterone. J Hypertens Suppl 1991; 9:S244-S245.
28. El-Dahr S, Yosipiv I: Developmentally regulated kallikrein enzymatic activity and gene transcription rate in maturing rat kidneys. Am J Physiol 1993; 265:F146-F150.
29. Clements JA, Fuller PJ, McNally M, Nikolaidis I, Funder JW: Estrogen regulation of kallikrein gene expression in the rat anterior pituitary. Endocrinology 1986; 119: 268-273.
30. Gerald WL, Chao J, Chao L: Sex dimorphism and hormonal regulation of rat tissue kallikrein mRNA. Biochim Biophys Acta 1986; 867: 16-23.
31. Senior J, Whalley ET: Variations in the estrogen-progesterone ratio and its effect on plasma kininogen levels in the rat. J Reprod Fert 1974; 425-433.
32. Chen LM, Chung P, Chao S, Chao L, Chao J: Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. Biochim Biophys Acta 1992; 1131: 45-51.